XDR-<i>Pseudomonas aeruginosa</i> Outside the ICU: Is There Still Place for Colistin?
Background: <i>Pseudomonas aeruginosa</i> represents, among the nosocomial pathogens, one of the most serious threats, both for the severity of its clinical manifestations and its ability to develop complex profiles of resistance; Methods: we retrospectively collected the data of 21 pati...
Saved in:
Main Authors: | Paola Del Giacomo (Author), Francesca Raffaelli (Author), Angela Raffaella Losito (Author), Barbara Fiori (Author), Mario Tumbarello (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Drugs for the Treatment of <i>Pseudomonas aeruginosa</i> Infections with Limited Treatment Options: A Narrative Review
by: Angela Raffaella Losito, et al.
Published: (2022) -
Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of <i>Pseudomonas aeruginosa</i>
by: Ashish Kothari, et al.
Published: (2023) -
Genetic Alternatives for Experimental Adaptation to Colistin in Three <i>Pseudomonas aeruginosa</i> Lineages
by: Igor Chebotar, et al.
Published: (2024) -
Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical <i>Pseudomonas aeruginosa</i>
by: Valentina Laverde-Rojas, et al.
Published: (2020) -
Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of <i>Pseudomonas aeruginosa</i> Phages
by: Katarzyna M. Danis-Wlodarczyk, et al.
Published: (2021)